ImmunologyPathogens and ImmunityPeer-reviewed
Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
Delphine Planas, Isabelle Staropoli, Cyril Planchais…·Olivier Schwartz
The paper evaluates the neutralization activity of two new monoclonal antibodies against emerging SARS-CoV-2 variants and finds reduced efficacy against some sublineages.
52 citationstop 1%